Logotype for ALK-Abelló

ALK-Abelló (ALK) investor relations material

ALK-Abelló Q2 2025 earnings summary

Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.
Logotype for ALK-Abelló
Q2 2025 earnings summary26 Aug, 2025

Executive summary

  • Q2 2025 delivered 12% organic revenue growth, with strong commercial execution and performance in Europe and North America, while International markets saw flat growth due to shipment phasing.

  • Operating profit (EBIT) rose 41% to DKK 375 million in Q2 and 46% to DKK 844 million in H1, with EBIT margin improving to 25% in Q2 and 28% in H1.

  • Tablet sales increased 16%, especially in Europe (+17%) and North America (+32%), while anaphylaxis revenue surged 56%, mainly from JextⓇ sales.

  • Roll-outs of ACARIZAXⓇ and ITULAZAX® for children, and the launch of EURneffyⓇ/neffyⓇ adrenaline spray, contributed to growth.

  • Free cash flow for H1 more than doubled to DKK 546 million, supported by higher earnings.

Financial highlights

  • H1 2025 revenue reached DKK 3,049 million, up 12% year-over-year; Q2 revenue was DKK 1,527 million.

  • Gross profit increased to DKK 2,011 million, with gross margin improving to 66% in H1 and 65% in Q2.

  • H1 EBIT was DKK 844 million (+46%), and H1 net profit was DKK 617 million (up from DKK 433 million).

  • Free cash flow for H1: DKK 546 million (up from DKK 272 million).

  • H1 EPS: 2.8 (H1 2024: 2.0); equity ratio: 71%.

Outlook and guidance

  • 2025 revenue growth now expected at 12-14% in local currencies (previously 9-13%).

  • EBIT margin forecasted at ~25% for 2025, up 5 percentage points, driven by revenue and gross margin improvements.

  • Double-digit growth anticipated in tablet and anaphylaxis product sales; single-digit growth in SCIT/SLIT-drops.

  • R&D expenses to increase double digits, mainly for peanut tablet and clinical trials.

  • Free cash flow for 2025 expected at DKK 600-800 million; CAPEX at DKK 350-400 million.

Partial view of Summaries dataset, powered by Quartr API
Research faster. Power your platform.

Next ALK-Abelló earnings date

Logotype for ALK-Abelló
Q3 202513 Nov, 2025
Your earnings 
season toolkit.
Download
Free on both iOS & Android.

Next ALK-Abelló earnings date

Logotype for ALK-Abelló
Q3 202513 Nov, 2025

The essential earnings season companion

The #1 app for live earnings calls, transcripts, analyst estimates, and more. All for free.

Live calls and transcripts

Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.

Find what you need faster

Search for any keyword across all transcripts simultaneously.

Easily store key findings

Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.

Your watchlist. Your dashboard.

Follow the companies that matter to you. Get a personalized feed with real-time updates.

Be the first to know

Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.

Consensus estimates

Access analyst consensus estimates, valuation multiples, and revenue segments splits.

All IR material in one place

The easiest way to stay updated during earnings season.

Global coverage

All events from public companies. Live and recorded.

Just click and listen

No webcast links. No manual registrations.

Research anytime, anywhere

Built for professionals. Loved by everyone. Try our free mobile app.

excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
App-store-avatar.png play-store-avatar.png
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
play-store-avatar
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
App-store-avatar.png play-store-avatar.png
anuj283App Store
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
App-store-avatar.png play-store-avatar.png
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
play-store-avatar
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
App-store-avatar.png play-store-avatar.png
anuj283App Store
I can't remember the last time an app had such a positive impact on my investment process.
x-avatar
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
App-store-avatar.png play-store-avatar.png
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
x-avatar
@theshortbearx.com
I can't remember the last time an app had such a positive impact on my investment process.
x-avatar
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
App-store-avatar.png play-store-avatar.png
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
x-avatar
@theshortbearx.com

Frequently asked questions

ALK-Abelló A/S operates as an allergy solutions company in Europe, North America, and internationally. The company produces test kits for allergy and asthma assessment; allergy alert systems; blood pressure monitors; clinical chemistry analyzers; immunoassays and biochemistry instruments, Bruker X-ray fluorescence spectrometers, and various other products. It also provides allergy diagnostic solutions, including skin testing systems; test kits to identify urushiols that cause natural rubber allergies; laboratory equipment to measure patient serum samples suspected of having restricted proteins; a compact EDM device that helps dermatologists treat contact dermatitis via electromagnetic healing vibrations; a patch test panel to help prevent hospital patients from developing hypersensitivity and subsequent allergies during their stay; a test kit for the identification of contact urticaria triggered by nickel based alloys used in jewellery making and dental implants.

Quartr provides global coverage of all investor relation material from public companies.

  • Mobile app: Research anytime, anywhere with the #1 app for live earnings calls, transcripts, analyst estimates, and more. All for free.

  • Desktop (Quartr Pro): The leading platform for qualitative research, used daily by top firms and financial institutions.

  • Quartr API: Build custom solutions powered by live earnings calls, live transcripts, filings and reports, slide presentations, and more.

Yes, the Quartr mobile app is free on both iOS and Android.

Yes. Quartr provides global, industry-leading live coverage of company events such as regular earnings calls, capital markets days, M&A announcements, and investor conferences. Live with zero delays. Just click and listen.

Yes, capturing important takeaways is as simple as it gets. Even during your lunch run or commute.

Yes. Follow the companies that matter to you. Get a personalized feed with real-time updates, a tailored earnings calendar, and instant alerts when earnings calls go live.

Yes. Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned, regardless of who's talking.

Explore our global coverage